Doctor’s Prescription Made Mandatory for Cough Syrups

The Union Ministry of Health and Family Welfare made a doctor’s prescription mandatory for the purchase of syrup medicines, including cough syrups, on 16 June 2026. The change took effect immediately after the publication of the Drugs (Fifth Amendment) Rules, 2026, in the Official Gazette.

Drugs Rules and Schedule K

The Drugs Rules, 1945, govern the manufacture, sale, and distribution of medicines in India. Schedule K of the Drugs Rules, 1945, lists categories of medicines exempt from certain regulatory provisions. The amendment removes the word “syrups” from Schedule K, which places syrup-based formulations under prescription control.

Prescription Requirement for Syrup Formulations

Commonly sold cough syrups such as Benadryl, Glycodin, Zedex, Tusq DX, Grilinctus, Cofsils, Himalaya Koflet, and Dabur Honitus now require a valid prescription. Lozenges, pills, and tablets used for cough treatment continue to remain exempt under Schedule K and can be purchased over the counter.

Regulatory Process

The amendment followed a draft notification issued in December 2025. The government considered objections and suggestions received from the public and consulted the Drugs Technical Advisory Board before finalising the rule change.

Public Health Context

The prescription rule covers syrup-based formulations after contamination-linked deaths among children in recent years in Madhya Pradesh and Rajasthan. The regulatory change applies to syrup medicines sold in India under the Drugs Rules, 1945.

Important Facts for Exams

• The Drugs Rules, 1945, are framed under India’s drug regulatory framework for manufacture, sale, and distribution of medicines.
• Schedule K contains medicines exempt from certain provisions of the Drugs Rules, 1945.
• The Official Gazette is the formal publication used for notifying legal and regulatory changes in India.
• The Drugs Technical Advisory Board is a statutory body associated with drug regulation in India.